Dabigatran protocol open for comment until Jan. 13

Candace Stuart | | Cardiovascular Business | Heart Rhythm

Physicians or others who want to weigh in on a draft protocol to assess safety outcomes in atrial fibrillation patients newly treated with dabigatran or warfarin have until Jan. 13 to submit comments.

The Mini-Sentinel Operations Center made a final draft protocol available online for public comment. The protocol is designed to provide a one-time assessment of rates of bleeding and thromboembolic outcomes with the two anticoagulants.

A workgroup led by Alan S. Go, MD, of Kaiser Permanente Northern California in Oakland; Joshua Gagne, PharmD, ScD, of Brigham and Women's Hospital in Boston; and Marsha Reichman, PhD, and David Graham, MD, MPH, of the FDA, will review comments. Revisions, if they occur, will be noted and included in an amended protocol.

Dabigatran (Pradaxa, Boehringer Ingelheim) is an oral direct thrombin inhibitor that was approved by the FDA in 2010 to reduce the risk of ischemic stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The FDA sponsors the Mini-Sentinel as part of surveillance efforts to monitor the safety of regulated products.  

The protocol is available here. Comments can be submitted by email to info@mini-sentinel.org.

Candace Stuart, Contributor

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup